Screener/Healthcare/Biotechnology

COGT

Cogent Biosciences, Inc.NASDAQ
$36.13+1.15 (+3.29%)
Mid CapUnder $50HealthcareLow Beta
$3.72
$43.73
$35.66
$36.32
EPS (TTM)$-2.16
P/E Ratio—
Dividend Yield—
Market Cap$5.62B
Volume75K
Prev Close$34.96
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$102.5M$-0.61——
Q3 '25$0-$80.9M$-0.50——
Q2 '25$0-$73.5M$-0.53——
Q1 '25$0-$72.0M$-0.52——
Q4 '24$0-$67.9M$-0.09——
Q3 '24$0-$70.6M$-0.64——
Q2 '24$0-$59.0M$-0.59——
Q1 '24$0-$58.3M$-0.62——
Get Your Daily Market Recap